These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10496200)

  • 1. Growth hormone therapy for heart failure: swimming against the stream.
    Saccà L
    J Card Fail; 1999 Sep; 5(3):269-75. PubMed ID: 10496200
    [No Abstract]   [Full Text] [Related]  

  • 2. Growth hormone as a potential future therapy for congestive heart failure.
    Fazio S; Cittadini A; Biondi B; Palmieri EA; Saccà L
    Coron Artery Dis; 1999 Sep; 10(6):383-8. PubMed ID: 10474788
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective beta1-blockade attenuates post-infarct remodelling without improvement in myocardial energy metabolism and function in rats with heart failure.
    Omerovic E; Bollano E; Soussi B; Waagstein F
    Eur J Heart Fail; 2003 Dec; 5(6):725-32. PubMed ID: 14675850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac effects of growth hormone.
    Dreifuss P
    Circulation; 2004 Jun; 109(25):e332. PubMed ID: 15226241
    [No Abstract]   [Full Text] [Related]  

  • 5. Growth hormone therapy in heart failure: a novel therapy worthy of further consideration?
    Demers C; McKelvie RS
    Expert Opin Investig Drugs; 2005 Aug; 14(8):1009-18. PubMed ID: 16050793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone therapy in heart failure: where are we now?
    Demers C; McKelvie RS
    Congest Heart Fail; 2003; 9(2):84-90. PubMed ID: 12671339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant bovine growth hormone-induced reduction of atrial natriuretic peptide is associated with improved left ventricular contractility and reverse remodeling in cardiomyopathic UM-X7.1 hamsters with congestive heart failure.
    Mulumba M; Céméus C; Dumont L; du Souich P; Ong H; Marleau S
    Growth Horm IGF Res; 2007 Apr; 17(2):96-103. PubMed ID: 17280860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy.
    Osterziel KJ; Strohm O; Schuler J; Friedrich M; Hänlein D; Willenbrock R; Anker SD; Poole-Wilson PA; Ranke MB; Dietz R
    Lancet; 1998 Apr; 351(9111):1233-7. PubMed ID: 9643742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G-Protein-Coupled Receptors in Heart Disease.
    Wang J; Gareri C; Rockman HA
    Circ Res; 2018 Aug; 123(6):716-735. PubMed ID: 30355236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone in the treatment of heart failure: a new tool for the future?
    Jonkman FA; De Jong G; Fioretti PM
    Eur Heart J; 1997 Feb; 18(2):181-4. PubMed ID: 9043830
    [No Abstract]   [Full Text] [Related]  

  • 11. The growth hormone IGF-I axis in dilated cardiomyopathy.
    Jenkins RC; Ross RJ
    Clin Endocrinol (Oxf); 1999 Apr; 50(4):415-6. PubMed ID: 10468899
    [No Abstract]   [Full Text] [Related]  

  • 12. The potential for growth hormone in the management of heart failure.
    Monson JP; Besser GM
    Heart; 1997 Jan; 77(1):1-2. PubMed ID: 9038681
    [No Abstract]   [Full Text] [Related]  

  • 13. Hormone Therapy to Treat Cardiac Remodeling: Is There Any Evidence?
    Cicchetto LA; Polegato BF; Zornoff LA
    Arq Bras Cardiol; 2016 Jul; 107(1):2-3. PubMed ID: 27533367
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of congestive heart failure. Has the time come for decreased complexity?
    Rydén L; Remme WJ
    Eur Heart J; 1999 Jun; 20(12):867-71. PubMed ID: 10329091
    [No Abstract]   [Full Text] [Related]  

  • 15. Astragaloside IV inhibits ventricular remodeling and improves fatty acid utilization in rats with chronic heart failure.
    Tang B; Zhang JG; Tan HY; Wei XQ
    Biosci Rep; 2018 May; 38(3):. PubMed ID: 29301869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of lisinopril on cardiac remodeling in patients with cardiosclerosis after myocardial infarction and signs of chronic heart failure].
    Blagodar VN; Petriĭ VV; Makolkin VI
    Kardiologiia; 2003; 43(9):17-20. PubMed ID: 14682288
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of Long-term Blockade of Vasopressin Receptor Types 1a and 2 on Cardiac and Renal Damage in a Rat Model of Hypertensive Heart Failure.
    Ikeda T; Iwanaga Y; Watanabe H; Morooka H; Akahoshi Y; Fujiki H; Miyazaki S
    J Cardiovasc Pharmacol; 2015 Nov; 66(5):487-96. PubMed ID: 26248278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentaerythritol Tetranitrate Targeting Myocardial Reactive Oxygen Species Production Improves Left Ventricular Remodeling and Function in Rats With Ischemic Heart Failure.
    Fraccarollo D; Galuppo P; Neuser J; Bauersachs J; Widder JD
    Hypertension; 2015 Nov; 66(5):978-87. PubMed ID: 26351025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restoration of thyroid hormone balance: a game changer in the treatment of heart failure?
    Gerdes AM
    Am J Physiol Heart Circ Physiol; 2015 Jan; 308(1):H1-10. PubMed ID: 25380818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arrhythmogenic remodeling of β2 versus β1 adrenergic signaling in the human failing heart.
    Lang D; Holzem K; Kang C; Xiao M; Hwang HJ; Ewald GA; Yamada KA; Efimov IR
    Circ Arrhythm Electrophysiol; 2015 Apr; 8(2):409-19. PubMed ID: 25673629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.